Few things are more local than a consequential Minnesota snowfall. I guess it’s time for me to get a new set of snow tires.

This marks Deel's fourth major acquisition of 2024, following integrations with Global Payroll (Payspace), Deel Engage (Zavvy ...

CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist.

But – as Wolfram acknowledged in his keynote – generative systems and LLMs are just a small branch of AI. Others may indeed ...

Discover how millennials are redefining success by leaving 'dream jobs' for more balanced, fulfilling careers.

As temperatures rise globally, winter sports are being forced to acclimate. Cancelled competitions, safety concerns, and an ...

Investors appeared disappointed by CagriSema’s Phase III readout, which showed weight loss that fell short of Novo Nordisk’s ...

The Danish company has announced positive results from its Phase III trial of CagriSema but fell short of a previously ...

Emerging technologies like Kubernetes, Docker, hybrid-multi-cloud architectures, and edge computing are poised to redefine ...

Novo Nordisk's CagriSema Phase 3 data showed 22.7% weight loss, missing the company's own 25% target, causing a 20% drop in ...

Novo Nordisk today announced headline results from REDEFINE 1, a phase 3 trial in the global REDEFINE programme. REDEFINE 1 is a 68-week efficacy and safety trial ...

Analysts say the XRP price is poised to hit the $10 mark, but the major focus is on the Ripple rival, PCHAIN, projected to ...